SWOG clinical trial number
S0316

Barriers to Accrual to Clinical Trials in Older (>= 65 Years) Cancer Patients

Closed
Phase
Accrual
97%
Published
Abbreviated Title
Barriers to Accrual
Status Notes
Activated
08/01/2004
Closed
06/15/2008
Participants
Limited: Institutions Listed on the Title Page

Eligibility Criteria Expand/Collapse

Pts must have a dx of breast, lung, or colorectal Ca. (Effective 4/15/07, the lung and colorectal strata are closed). Pts must be seen at the participating clinics listed on the title page of the protocol. For each pt seen at the clinic who is eligible, it is expected that one of the following two action will occur w/in 24 hrs: a) the pt will be assessed, consented, and registered OR b) the pt will be logged as a "non-participant". Note: Pts w/ anal cancer are eligible. Pts must either be new to the inst, or a known pt w/ a new dx of Ca/ new stage of Ca. Pts must be ready to initiate systemic therapy of any type. Prior involvement in a clinical trial is allowed. Pts must be under consideration for tx of their ca w/ systemic therapy. Pts under consideration for srg or RT tx alone are not eligible. Pts must not have a current psychiatric dx that would interfere w/ ability to participate. Pts must be able to read and understand English. Pts must be willing to complete required forms. Reg must occur w/in 24 hours of the initial physican consult for determination of systemic tx options. If a consult occurs on a Friday, the pt must be registered the following Monday. Similarly, if the consult occurs the day before a holiday, the pts must be registered to the study the next buisness day. Pt must >= 18 yo. The principal investigator at each site must completed and submitted the Site PI Inititation Form.

Publication Information Expand/Collapse

2020

Beyond Patient-Level Barriers: Evaluation of Rural Residency and Area-Level Deprivation and Clinical Trial Participation

J Unger;A Moseley;G Doolittle;R Osarogiagbon;D Hershman J Clin Oncol 38: 2020 (suppl; abstr e19068); American Society of Clinical Oncology 2020 Annual Meeting, publication only

2016

Patient income level and cancer clinical trial participation in a prospective survey study [Research Letter]

JM Unger;JR Gralow;KS Albain;S Ramsey;DL Hershman JAMA Oncology, Jan 1;2(1):137-139

PMid: PMID26468994 | PMC number: PMC4824189

2014

Enhancing nurse contributions to SWOG clinical trials

L Hansen;C Moinpour;R Ermete Seminars in Nursing Oncology 30(1):26-31;

PMid: PMID24559777 | PMC number: PMC3961058

2012

A prospective analysis of the influence of older age on physician decision-making when considering enrollment to breast cancer clinical trials (SWOG S0316)

S Javid;J Unger;J Gralow;C Moinpour;A Wozniak;JW Goodwin;P Lara;PA Williams;L Hutchins;C Gotay;K Albain The Oncologist 17(9):1180-1190;

PMid: PMID22723506 | PMC number: PMC3448411

2009

The influence of older age on physician and patient decision-making regarding enrollment to breast cancer clinical trials

S Javid;J Unger;J Gralow;C Moinpour;A Wozniak;JW Goodwin;P Lara;P Williams;L Hutchins;C Gotay;K Albain San Antonio Breast Cancer Symposium, poster, abst. #3077